| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966148 | Vaccine | 2013 | 10 Pages |
Abstract
Altogether, our study confirms the efficacy and the safety of flu vaccine in SLE patients, highlights the role of CXCR4 as a surrogate marker for autoimmunity in lupus and shows that CXCR4 expression on T cells is predictive of vaccine efficacy in SLE patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Odile Launay, Stéphane Paul, Amélie Servettaz, Gwénaëlle Roguet, Flore Rozenberg, Frédéric Lucht, Claude Lambert, Emilie Presles, Claire Goulvestre, Jean-François Méritet, Florence Galtier, Claude Dubray, Pierre Lebon, Bernard Weill,